IndraLab

Statements


BRAF binds KRAS and CHD5. 1 / 1
| 1

sparser
"In fact, other mechanisms have been suggested in other types of tumors, as CHD5 mutation or methylation is associated with KRAS or BRAF mutation in ovarian cancer [ xref ], and CHD5 expression correlates with MYCN amplification in neuroblastoma [ xref , xref ]."